Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism.

Volume: 69, Issue: 3, Pages: 625 - 633
Published: Jun 27, 2020
Abstract
Primary aldosteronism (PA) is the most frequent form of endocrine hypertension. Besides its deleterious impact on cardiovascular target organ damage, PA is considered to cause osteoporosis. We assessed bone turnover in a subset of 36 postmenopausal women with PA. 18 patients had unilateral PA and were treated by adrenalectomy, whereas 18 patients had bilateral PA and received mineralocorticoid receptor antagonist (MRA) therapy respectively. 18...
Paper Details
Title
Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism.
Published Date
Jun 27, 2020
Journal
Volume
69
Issue
3
Pages
625 - 633
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.